dc.contributor.advisor | Alam, Marzia | |
dc.contributor.author | Islam, Md. Rakibul | |
dc.date.accessioned | 2023-05-08T03:48:34Z | |
dc.date.available | 2023-05-08T03:48:34Z | |
dc.date.copyright | 2022 | |
dc.date.issued | 2022-02 | |
dc.identifier.other | ID 16146056 | |
dc.identifier.uri | http://hdl.handle.net/10361/18232 | |
dc.description | This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022. | en_US |
dc.description | Cataloged from PDF version of thesis. | |
dc.description | Includes bibliographical references (pages 46-47). | |
dc.description.abstract | "Parkinson’s Disease (PD) is considered as one of the highest occurring neurodegenerative
disorders. Motor complexities are the major symptoms of this disease which mainly includes bradykinesia, rigidity and tremor. Moreover, the non-motor symptoms can be included as mental and psychological complexities. Injury to the dopamine pathways is considered as the primary pathological reason of PD. Although the older population represents the majority of the patients, 5- 10% of the patients are relatively younger. Currently, dopamine replacement therapy with levodopa is the most common mode of treatment for alleviating the symptoms and retaining the functional capabilities. Here, gene therapy can be a viable treatment approach for such neurodegenerative disorders since it serves by knocking down the pathological genes. Even though few questions are yet to be answered before incorporating gene therapy in Parkinson’s disease, this novel therapeutic
method has the potential to reshape the future of neurologic therapeutics." | en_US |
dc.description.statementofresponsibility | Md. Rakibul Islam | |
dc.format.extent | 47 pages | |
dc.language.iso | en | en_US |
dc.publisher | Brac University | en_US |
dc.rights | Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. | |
dc.subject | Neurodegenerative disorder | en_US |
dc.subject | Levodopa | en_US |
dc.subject | Gene therapy | en_US |
dc.subject | Dopamine replacement therapy | en_US |
dc.subject.lcsh | Parkinson’s disease | |
dc.title | A look into parkinson’s disease and the implications of gene therapy as a novel clinical approach | en_US |
dc.type | Thesis | en_US |
dc.contributor.department | Department of Pharmacy, Brac University | |
dc.description.degree | B. Pharmacy | |